Processing...
Processing...
Inmagic
®
Presto
Version 5.5 Build 151
Inmagic
®
Presto
Copyright © 2005-2021 by Lucidea Technologies Corp., Richmond BC Canada. All rights reserved.
Inmagic® and the Inmagic logo are registered trademarks of Lucidea Technologies Corp.
Unauthorized duplication or distribution is prohibited.
Other brand and product names are trademarks or registered trademarks of their respective holders. Use of any other product name does not imply endorsement of that product by Inmagic.
Third-party Licenses
Processing...
Processing...
Title
Risperidona para el trastorno del espectro autista
Subtitle
Risperidone for Autism Spectrum Disorder
Author
Jesner, Ora S.; Aref-Adib, Mehrnoosh; Coren, Esther
Summary
This online article, written in Spanish, summarizes a review of research evidence conducted to determine whether risperidone, an antipsychotic medication, is effective in treating symptoms and behavior in people on the autism spectrum. The review concludes that risperidone may reduce irritability, repetitive behavior, and hyperactivity in some people on the autism spectrum. However, the authors also note that there are side-effects including weight gain, and they suggest that further research is needed to compare long-term benefits and risks.
This resource is available in Chinese, English, French, and Spanish.
Cochrane is a “global independent network of researchers, professionals, patients, carers, and people interested in health.” [Website] The network reviews evidence about health treatments.
Language
Spanish
Subjects
Autistic Adults
Employment
Publisher
Cochrane
DateModified
9/22/2022 3:23 PM EDT